Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Chen-Han Wu, MD, PhD

Chen-Han Wu, MD, PhD

  • Specialty: Genetics, Urology
    View Expertise
  • Primary Location: 11100 Euclid Ave (0 mi.)
    Other Locations
  • Languages Spoken: English, Mandarin Chinese, Taiwanese

Office Locations

UH Cleveland Medical Center Lakeside (0 mi.)

11100 Euclid Ave
Lakeside Ste 1500
Cleveland, OH 44106
216-844-3936

Biography: Chen-Han Wu, MD, PhD

Expertise

  • Biochemical Genetics
  • Cancer Genetics
  • Urogenetics

Titles

  • Assistant Professor, CWRU School of Medicine

Certifications & Memberships

  • Clinical Biochemical Genetics - American Board of Medical Genetics and Genomics
  • Clinical Genetics and Genomics - American Board of Medical Genetics and Genomics

Education

Fellowship | Clinical Biochemical Genetics
Clinical Biochemical Genetics - Boston Children's Hospital (2020 - 2021)

Residency | Clinical Genetics and Genomics
Clinical Genetics and Genomics - Boston Children's Hospital (2017 - 2020)

Residency | General Surgery
General Surgery - University Of Colorado Hospital (2016 - 2017)

Post Doctorate Training | Molecular and Human Genetics
Molecular and Human Genetics - Baylor College Of Medicine - Texas Medical Center (2015 - 2016)

Post Doctorate Training | Genetics
Genetics - University Of Utah Hospital (2014 - 2015)

Professional Education
University Of Utah School Of Medicine (2013)

Medical Education
National Taiwan University College Of Medicine (2001)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Chen-Han Wu did not disclose any Outside Relationships with Industry.